1. Washington D.C., USA, 22-27 July 2012www.aids2012.org Is the scientific and programming community ignoring condoms— the visible yet invisible method proven to prevent the transmission of HIV? Global Village debate Thursday, July 26, 2012 16:30-17:30 Session Room 2

2. Washington D.C., USA, 22-27 July 2012www.aids2012.org Discussion questions Do you agree or disagree with the following statement?: The vital role that condoms play in the prevention of sexually transmitted infections including HIV is being underplayed by the scientific and international aid communities in favor of new prevention technologies.

3. Washington D.C., USA, 22-27 July 2012www.aids2012.org Discussion questions (cont.) Where do female and male condoms fit in the programming of new biomedical interventions or within the broader combination approach to HIV prevention? Are synergies in programming being fully realized—why or why not?

4. Washington D.C., USA, 22-27 July 2012www.aids2012.org Discussion questions (cont.) Many of you work on the front lines in HIV prevention and treatment. What “condom gaps” do you see? Are they different for male and female condoms?

5. Washington D.C., USA, 22-27 July 2012www.aids2012.org Discussion questions (cont.) Have we been effective in promoting male and female condoms? What needs to change? For example, have we focused too much on disease prevention rather than pleasure?

6. Washington D.C., USA, 22-27 July 2012www.aids2012.org Discussion questions (cont.) Is it an effective strategy for male and female condoms to be targeted solely for use by most-at- risk populations (MARPs)? What are the trade-offs? For instance, what does condom promotion directed at MARPs mean for married couples or sexually active single people and for stigmatization of condom use more generally?

7. Washington D.C., USA, 22-27 July 2012www.aids2012.org Discussion questions (cont.) Do we need to rethink our advocacy strategies? What are the key policy and financial barriers facing female and male condoms? What evidence and tactics are needed to overcome them?

8. Washington D.C., USA, 22-27 July 2012www.aids2012.org Final question What is your top recommendation to make promotion and use of male and female condoms more effective, particularly within the context of emerging prevention and treatment/prevention strategies?